| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |